Not Yet Recruiting
Prospective Evaluation of Subcutaneous Administration of Daratumumab by the FreedomEDGE® Infusion System
NCT07721350
- Conditions
- Amyloidosis, Behavior, Blood Protein Disorders, +21 more
- Locations
-
- Hôpital Lyon-Sud Pierre-Bénite, France